Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Bone Marrow Transplantation
|
September 1, 1999
Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry
P McCarthy, D Hurd, P Rowlings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide
C Wheeler, M Strawderman, L Ayash, et al.
Cancer
|
November 1, 1993
The economic impact of therapy on cancer patients
G P Murphy, J Prestifilippo, K Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
K Antman, J Crowley, S P Balcerzak, et al.
Cancer
|
November 1, 1993
The impact of clinical trial protocols on patient care systems
W Lawrence, K Antman, H P Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin
L J Ayash, A Elias, G Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma
L J Ayash, A Elias, J Ibrahim, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Bone Marrow Transplantation
|
September 1, 1999
Autotransplants in men with breast cancer. ABMTR Breast Cancer Working Committee. Autologous Blood and Marrow Transplant Registry
P McCarthy, D Hurd, P Rowlings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B
A P Chahinian, K Antman, M Goutsou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide
C Wheeler, M Strawderman, L Ayash, et al.
Cancer
|
November 1, 1993
The economic impact of therapy on cancer patients
G P Murphy, J Prestifilippo, K Antman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
K Antman, J Crowley, S P Balcerzak, et al.
Cancer
|
November 1, 1993
The impact of clinical trial protocols on patient care systems
W Lawrence, K Antman, H P Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin
L J Ayash, A Elias, G Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma
L J Ayash, A Elias, J Ibrahim, et al.
Bone Marrow Transplantation
|
August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
L T Vahdat, C Balmaceda, K Papadopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamine
L Vahdat, K Papadopoulos, D Lange, et al.
Page
of 7